Cycloheximide is an antibiotic which inhibits eucaryotic protein synthesis. Although many yeasts including Saccharomyces cerevisiae are sensitive to cycloheximide, some yeast strains are resistant to this drug. Among the resistant strains, Candida maltosa IAM12247 has an inducible resistance mechanism, as described in our previous paper (12) . Results of in vitro protein synthesis with ribosomal and S-100 fractions prepared from cycloheximide-treated and -nontreated C. maltosa cells indicated that ribosomes are modified in the cells during cultivation in the presence of cycloheximide. It was suggested that there is a gene (designated RIM-C for ribosome modification by cycloheximide) which functions in the presence of cycloheximide in such a way as to modify ribosomes so that protein synthesis in the cells is no longer inhibited by cycloheximide. In this investigation, we attempted to clone this presumptive gene by using a host-vector system of S. cerevisiae. We believe that the cloning of this gene will not only help to analyze the mechanism of cycloheximide resistance related to the RIM-C gene in C. maltosa, but also will provide a convenient dominant vector marker for recombinant DNA technology with S. cerevisiae.
Strains used in this work were C. maltosa IAM12247 (12), S. cerevisiae AH22 (a leu2-3 leu2-112 his4-519 cani gal2) (4), S. cerevisiae IF01265 (12) , Escherichia coli MC1061 [hsdR hsdM+ araD139 A(ara-leu)7697 AlacX74 rpsL GalK-] (2), and E. coli JA221 (recAl leuB6 trpE5 hsdR hsdM+ lacI thr thi) (9) . The media for cultivation (SD and YPD for yeasts; Luria broth and Davis medium for E. coli), transformation, and regeneration of the spheroplasts of yeast cells were as described previously (8) . The lithium acetate method was also used for transformation of S. cerevisiae (5 with HindIII, and the resulting four fragments containing C. maltosa DNA were ligated with HindlIl-digested plasmid YEp13 and transformed into S. cerevisiae. From Cyhr clones, pRIM-C2 was recovered. Then pRIM-C2 was double-digested with XbaI and Sau3A1, and a BamHI linker was added to both ends of each fragment, ligated to the BamHIdigested YEp13 plasmid, and transformed into S. cerevisiae. pRIM-C3 was isolated from Cyhr clones.
In vitro protein synthesis and preparation of salt-washed ribosomes and the S-100 fraction were done as described previously (12) . These two fractions were prepared from cells of S. cerevisiae AH22(pRIM-C2) grown in the presence of 25 pLg of cycloheximide per ml and from cells of S. cerevisiae IF01265 as the control (12) .
To clone the presumptive gene of C. maltosa responsible for cycloheximide resistance, S. cerevisiae AH22 (leu2) was S H transformed by the lithium acetate method with a gene bank constructed in vector YEp13 (LEU2+). Leu+ colonies were isolated and confirmed for their Leu+ phenotype. They were spread on YPD agar containing 10 ,ug of cycloheximide per ml. Of 1,050 Leu+ clones tested, 2 were Cyhr. Plasmid DNA was isolated from both of them, transformed, and amplified in E. coli JA221, and the structures of both were analyzed by restriction enzymes. It was found that they were identical to each other (Fig. 1) . A representative plasmid was designated pRIM-Cl (15.4 kb); it had a 4.7-kb insert of C. maltosa genomic DNA in the 10.7-kb YEp13 vector. Subcloning of the fragment was performed as described above (pRIM-C2 was obtained as shown in Fig. 1 ). S. cerevisiae AH22 carrying this plasmid made colonies even in the presence of 1 mg of cycloheximide per ml, but S. cerevisiae AH22 itself was sensitive to cycloheximide at 0.2 ,ug/ml.
To determine whether ribosome modification occurred in S. cerevisiae(pRIM-C2), as it did in C. maltosa, in vitro protein synthesis was done. When ribosomes from cycloheximide-treated S. cerevisiae(pRIM-C2) were used in combination with fraction S-100 from either cycloheximide-treated S. cerevisiae(pRIM-C2) (Fig. 2a) or nontreated S. cerevisiae IF01256 (data not shown), the incorporation activity was scarcely influenced by the presence of cycloheximide at 2.5 or 25 ,ug/ml. In contrast, in the systems containing ribosomes from the control S. cerevisiae, the incorporation activity was inhibited by cycloheximide irrespective of the origin of the S-100 [S-100 from cycloheximide-treated S. cerevisiae(pRIM-C2), (Fig. 2b) or S-100 from the control S. cerevisiae (data not shown)]. From these results, we concluded that the RIM-C gene cloned in the pRIM-C2 plasmid modifies ribosomes so that they become resistant to cycloheximide.
Several dominant vector markers have been recognized in S. cerevisiae (3, 6, 7, 10, 11) . To use the RIM-C gene as a selectable marker of plasmids in S. cerevisiae, we recommend the following procedure. S. cerevisiae AH22 is transformed with pRIM-C2 (or pRIM-C3) by the spheroplast method. The spheroplasts are mixed with about 20 ml of YPD containing 3% agar and 1.2 M sorbitol, poured into a petri dish, and incubated overnight at 30°C. The next morning, about 10 ml of YPD containing 0.6% agar and 5 ,ug of cycloheximide per ml is poured onto the dish, which is then incubated at 30°C. After 3 to 5 days, only those cells carrying pRIM-C2 (or pRIM-C3) make colonies. By this procedure, it was confirmed that S. cerevisiae AH22 carrying either of these plasmids can be isolated without using LEU2' as a selectable marker. The numbers of LEU2+ colonies and Cyhr colonies were almost the same when these colonies were selected and counted separately. The RIM 
